host cell surface receptor binding [MF]
Toll-like receptor 4 binding [MF],
somatotropin secreting cell development [BP],
positive regulation of toll-like receptor 3 signaling pathway [BP],
N-acetylglucosamine-6-phosphate deacetylase activity [MF],
positive regulation of toll-like receptor 2 signaling pathway [BP],
TIRAP-dependent toll-like receptor 4 signaling pathway [BP],
positive regulation of interleukin-15 production [BP],
Toll-like receptor 2 binding [MF]
voltage-gated sodium channel activity involved in regulation of Purkinje myocyte action potential [MF],
membrane depolarization involved in regulation of Purkinje myocyte cell action potential [BP]
protein N-linked glycosylation [BP],
protein N-linked glycosylation via asparagine [BP]
spermine biosynthetic process [BP],
adenosylmethionine decarboxylase activity [MF]
negative regulation of G2 phase of mitotic cell cycle [BP],
negative regulation of convergent extension involved in axis elongation [BP],
positive regulation of metanephric cap mesenchymal cell proliferation [BP]
positive regulation of heart rate by epinephrine [BP],
D4 dopamine receptor binding [MF],
D2 dopamine receptor binding [MF],
phospholipid-hydroperoxide glutathione peroxidase activity [MF]
negative regulation of mitochondrial membrane potential [BP]
G-quadruplex RNA binding [MF],
isocitrate hydro-lyase (cis-aconitate-forming) activity [MF],
phosphopantothenate--cysteine ligase activity [MF],
citrate hydro-lyase (cis-aconitate-forming) activity [MF],
establishment of protein localization to chromatin [BP]
core TFIIH complex [CC]
type 2A serotonin receptor binding [MF],
alpha-1A adrenergic receptor binding [MF],
3-mercaptopyruvate sulfurtransferase activity [MF],
follicle-stimulating hormone signaling pathway [BP],
negative regulation of natural killer cell mediated cytotoxicity [BP],
desensitization of G-protein coupled receptor protein signaling pathway by arrestin [BP],
thiosulfate sulfurtransferase activity [MF],
alpha-1B adrenergic receptor binding [MF],
follicle-stimulating hormone receptor binding [MF],
D1 dopamine receptor binding [MF]
histone H2A K63-linked deubiquitination [BP],
positive regulation of transcription from RNA polymerase II promoter in response to oxidative stress [BP],
positive regulation of oxygen metabolic process [BP],
cadmium ion homeostasis [BP]
antibiotic metabolic process [BP],
cytoskeletal adaptor activity [MF],
nuclear speck [CC]
regulation of cell morphogenesis [BP],
odontoblast differentiation [BP],
D3 dopamine receptor binding [MF],
dentinogenesis [BP],
osteoclast maturation [BP],
T cell aggregation [BP]
Arp2/3 complex binding [MF],
histone methyltransferase activity (H4-K20 specific) [MF],
histone methyltransferase activity (H3-K36 specific) [MF]
acetylpyruvate hydrolase activity [MF],
fumarylpyruvate hydrolase activity [MF],
acylpyruvate hydrolase activity [MF],
geranylgeranyl diphosphate biosynthetic process [BP]
PML body [CC],
(S)-limonene 6-monooxygenase activity [MF],
positive regulation of maintenance of mitotic sister chromatid cohesion [BP],
(R)-limonene 6-monooxygenase activity [MF],
interferon-gamma binding [MF],
(S)-limonene 7-monooxygenase activity [MF]
vacuolar acidification [BP]
positive regulation of dopamine uptake involved in synaptic transmission [BP],
olfactory learning [BP],
iodide peroxidase activity [MF],
negative regulation of voltage-gated calcium channel activity [BP],
tripeptidase activity [MF]
positive regulation of transcription from RNA polymerase II promoter during mitosis [BP]
ATP-dependent 5'-3' RNA helicase activity [MF],
uridine transport [BP]
DNA replication proofreading [BP],
glucuronyl-galactosyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity [MF]
microtubule basal body [CC],
centriole [CC],
response to prostaglandin F stimulus [BP]
amine metabolic process [BP]
histone kinase activity (H3-T6 specific) [MF],
positive regulation of dense core granule biogenesis [BP],
UTP:glucose-1-phosphate uridylyltransferase activity [MF]
sperm displacement [BP],
prominosome [CC]
positive regulation of alpha-beta T cell differentiation [BP],
neurotrophin p75 receptor binding [MF],
positive regulation of ERK1 and ERK2 cascade [BP]
transmembrane transport [BP],
L-hydroxyproline transmembrane transporter activity [MF],
threonine transport [BP],
L-threonine transmembrane transporter activity [MF]
muramyl dipeptide binding [MF],
macrophage inflammatory protein-1 alpha production [BP],
positive regulation of biosynthetic process of antibacterial peptides active against Gram-positive bacteria [BP],
positive regulation of dendritic cell cytokine production [BP],
detection of muramyl dipeptide [BP],
activation of MAPK activity involved in innate immune response [BP],
microglial cell activation involved in immune response [BP],
pathogen-associated molecular pattern dependent induction by symbiont of host innate immune response [BP],
positive regulation of prostaglandin-E synthase activity [BP],
myo-inositol:sodium symporter activity [MF]
MCM8-MCM9 complex [CC]
negative regulation of calcium-dependent cell-cell adhesion [BP]
receptor tyrosine kinase binding [MF],
regulation of interferon-gamma-mediated signaling pathway [BP]
Pyrin domain binding [MF],
taurine:sodium symporter activity [MF],
taurine transport [BP]
peptidyl-prolyl cis-trans isomerase activity [MF]
negative regulation of striated muscle contraction [BP],
integral to plasma membrane [CC]
glutaryl-CoA dehydrogenase activity [MF],
alphav-beta3 integrin-IGF-1-IGF1R complex [CC],
entry of symbiont into host cell by promotion of host phagocytosis [BP],
citrate-L-glutamate ligase activity [MF]
retinoic acid metabolic process [BP]
pseudouridylate synthase activity [MF]
cellular protein metabolic process [BP],
regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle [BP],
cellular protein modification process [BP],
anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process [BP]
positive regulation of mismatch repair [BP],
maintenance of ER location [BP],
carbonate dehydratase activity [MF],
bicarbonate transport [BP],
hydroxylysine biosynthetic process [BP],
rough endoplasmic reticulum [CC]
malonyl-CoA catabolic process [BP],
AP-type membrane coat adaptor complex [CC],
clathrin adaptor complex [CC],
acetylcholine biosynthetic process [BP],
malonyl-CoA decarboxylase activity [MF],
acetoacetate-CoA ligase activity [MF]
vestibular reflex [BP]
dentate gyrus mossy fiber [CC]
negative regulation of interleukin-12 biosynthetic process [BP],
menopause [BP],
catalase activity [MF]
negative regulation of viral reproduction [BP],
RNA binding [MF],
DNA cytosine deamination [BP],
negative regulation of transposition [BP],
negative regulation of retroviral genome replication [BP],
cytoplasmic mRNA processing body [CC],
cytidine deaminase activity [MF],
base conversion or substitution editing [BP],
apolipoprotein B mRNA editing enzyme complex [CC],
positive regulation of defense response to virus by host [BP],
negative regulation of viral genome replication [BP]
6-phosphogluconolactonase activity [MF]
high affinity arginine transmembrane transporter activity [MF],
central nervous system myelin maintenance [BP]
positive regulation of cellular glucuronidation [BP],
lipopolysaccharide-mediated signaling pathway [BP],
negative regulation of branching involved in lung morphogenesis [BP],
positive regulation of cell migration [BP],
positive regulation of smooth muscle cell proliferation [BP],
negative regulation of cell differentiation involved in embryonic placenta development [BP],
positive regulation of tubulin deacetylation [BP],
positive regulation of translational initiation by iron [BP],
positive regulation of synaptic transmission [BP],
negative regulation of L-glutamate transport [BP],
positive regulation of mononuclear cell migration [BP],
positive regulation of acute inflammatory response [BP]
cellular lactam catabolic process [BP],
glycoprotein 6-alpha-L-fucosyltransferase activity [MF]
response to vitamin B1 [BP]
endoplasmic reticulum [CC]
enkephalin receptor activity [MF]
zinc ion transmembrane transporter activity [MF]
negative regulation of uterine smooth muscle contraction [BP],
negative regulation of adrenergic receptor signaling pathway [BP],
adenylate cyclase-inhibiting adrenergic receptor signaling pathway [BP]
interphase microtubule organizing center [CC]
negative regulation of growth hormone receptor signaling pathway [BP],
Golgi to secretory granule transport [BP]
L-threonine catabolic process to glycine [BP],
nucleus accumbens development [BP]
bis(5'-nucleosyl)-tetraphosphatase (symmetrical) activity [MF],
arylformamidase activity [MF],
bis(5'-nucleosyl)-tetraphosphatase (asymmetrical) activity [MF]
C-terminal protein methylation [BP],
protein C-terminal carboxyl O-methyltransferase activity [MF],
zymogen binding [MF]
regulation of synaptic plasticity [BP],
phosphatidylinositol-3,4,5-trisphosphate 3-phosphatase activity [MF],
cellular component movement [BP],
uropod organization [BP],
smooth endoplasmic reticulum calcium ion homeostasis [BP],
brain morphogenesis [BP],
negative regulation of axonogenesis [BP],
Cajal-Retzius cell differentiation [BP],
inositol-1,3,4,5-tetrakisphosphate 3-phosphatase activity [MF],
negative regulation of ribosome biogenesis [BP],
positive regulation of proteasomal ubiquitin-dependent protein catabolic process [BP],
negative regulation of actin nucleation [BP],
mitotic spindle elongation [BP],
activation of mitotic anaphase-promoting complex activity [BP],
regulation of resting membrane potential [BP],
negative regulation of cyclin-dependent protein kinase activity involved in G1/S [BP],
gamma-secretase complex [CC],
T cell receptor signaling pathway [BP],
neuron-neuron synaptic transmission [BP],
negative regulation of synaptic vesicle clustering [BP],
phosphatidylinositol-3,4-bisphosphate 3-phosphatase activity [MF],
PDZ domain binding [MF]
cortical microtubule cytoskeleton [CC]
alpha-N-acetylglucosaminidase activity [MF],
acetyl-CoA:L-glutamate N-acetyltransferase activity [MF]
positive regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation [BP],
inactivation of X chromosome by DNA methylation [BP]
calcium-transporting ATPase activity involved in regulation of cardiac muscle cell membrane potential [MF]
positive regulation of tendon cell differentiation [BP],
galactosylxylosylprotein 3-beta-galactosyltransferase activity [MF]
superior olivary nucleus maturation [BP],
regulation of microtubule-based process [BP],
cerebral cortex development [BP]
positive regulation of chronic inflammatory response to non-antigenic stimulus [BP]
glycerol biosynthetic process from pyruvate [BP]
protein complex oligomerization [BP],
uniporter activity [MF]
brain-derived neurotrophic factor receptor signaling pathway [BP],
brain-derived neurotrophic factor-activated receptor activity [MF]
carbon tetrachloride metabolic process [BP]
regulation of chemokine production [BP],
leukocyte chemotaxis involved in inflammatory response [BP],
negative regulation of mast cell differentiation [BP],
negative regulation of interleukin-4 biosynthetic process [BP],
sterol homeostasis [BP]
phosphatidylinositol catabolic process [BP]
negative regulation of astrocyte differentiation [BP],
negative regulation of glial cell differentiation [BP],
MOZ/MORF histone acetyltransferase complex [CC]
beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity [MF],
lactose synthase activity [MF]
defense response to nematode [BP]
positive regulation of dense core granule biogenesis [BP],
histone kinase activity (H3-T6 specific) [MF],
desmosome assembly [BP],
positive regulation of lipopolysaccharide-mediated signaling pathway [BP],
histone H3-T6 phosphorylation [BP]
endomembrane system [CC]
striated muscle contraction [BP],
protein polyamination [BP]
regulation of transcription involved in S phase of mitotic cell cycle [BP]
very-low-density lipoprotein particle receptor activity [MF]
N-acetyl-beta-glucosaminyl-glycoprotein 4-beta-N-acetylgalactosaminyltransferase activity [MF],
condensed chromosome inner kinetochore [CC]
triglyceride binding [MF],
lipoprotein lipase activity [MF]
tetracycline metabolic process [BP],
negative regulation of intestinal cholesterol absorption [BP],
nucleoside triphosphate adenylate kinase activity [MF],
carbon tetrachloride metabolic process [BP]
core TFIIH complex [CC],
methylglyoxal biosynthetic process [BP],
glucose-6-phosphate isomerase activity [MF]
N-acetylneuraminate synthase activity [MF]
neuron projection [CC],
low-density lipoprotein particle mediated signaling [BP],
spinal cord ventral commissure morphogenesis [BP],
adiponectin binding [MF],
netrin receptor activity [MF],
maltose alpha-glucosidase activity [MF]
commissural neuron differentiation in spinal cord [BP],
mediator complex [CC],
taurine:sodium symporter activity [MF],
protein O-linked fucosylation [BP],
taurine transport [BP]
RNA polymerase I transcriptional preinitiation complex assembly at the promoter for the nuclear large rRNA transcript [BP],
positive regulation of mitochondrial outer membrane permeabilization [BP]
response to nickel cation [BP]
divalent metal ion export [BP],
3'-tyrosyl-DNA phosphodiesterase activity [MF],
nitrite transport [BP],
metal ion:hydrogen antiporter activity [MF]
iron-cytochrome-c reductase activity [MF],
nitric oxide catabolic process [BP]
steroid hormone receptor complex assembly [BP]
nucleotide-excision repair, DNA damage removal [BP]
response to fatty acid [BP]
positive regulation of metanephric cap mesenchymal cell proliferation [BP]
D-serine catabolic process [BP],
D-amino-acid oxidase activity [MF],
basophil chemotaxis [BP],
response to nickel cation [BP],
vascular endothelial growth factor receptor 1 binding [MF],
blue light photoreceptor activity [MF]
nucleotide-excision repair factor 1 complex [CC]
peptidyl-serine phosphorylation [BP]
presynaptic membrane [CC],
adiponectin binding [MF]
pronuclear fusion [BP],
erythropoietin-mediated signaling pathway [BP],
melanocyte migration [BP],
Kit signaling pathway [BP],
positive regulation of cell proliferation [BP],
neuronal ribonucleoprotein granule [CC],
stem cell factor receptor activity [MF],
melanocyte adhesion [BP]
negative regulation of chemokine biosynthetic process [BP]
DNA-directed RNA polymerase activity [MF]
lactation [BP]
pheromone binding [MF],
urotensin II receptor activity [MF]
histone H2A K63-linked deubiquitination [BP]
corticotropin-releasing hormone receptor activity [MF],
ubiquitin-dependent endocytosis [BP]
low-affinity glucose:sodium symporter activity [MF]
sodium:chloride symporter activity [MF]
condensed chromosome [CC],
negative regulation of fat cell differentiation [BP],
enkephalin receptor activity [MF],
negative regulation of collagen binding [BP],
negative regulation of protein binding [BP],
negative regulation of mast cell differentiation [BP],
megakaryocyte differentiation [BP],
negative regulation of interleukin-4 biosynthetic process [BP]
[3-methyl-2-oxobutanoate dehydrogenase (acetyl-transferring)] kinase activity [MF],
histone kinase activity (H3-T3 specific) [MF]
RNA-directed RNA polymerase activity [MF],
aldose 1-epimerase activity [MF],
oxidoreductase activity, oxidizing metal ions with flavin as acceptor [MF],
actin cytoskeleton reorganization [BP]
intracellular ferritin complex [CC]
establishment of protein localization to juxtaparanode region of axon [BP],
detection of chemical stimulus involved in sensory perception of sweet taste [BP],
sweet taste receptor activity [MF]
Edg-2 lysophosphatidic acid receptor binding [MF],
positive regulation of toll-like receptor 2 signaling pathway [BP],
TIRAP-dependent toll-like receptor 4 signaling pathway [BP],
positive regulation of transcription involved in G1/S phase of mitotic cell cycle [BP],
positive regulation of interleukin-15 production [BP],
Toll-like receptor 2 binding [MF]
fatty acid catabolic process [BP],
fatty acid amide hydrolase activity [MF],
fumarylpyruvate hydrolase activity [MF],
acylpyruvate hydrolase activity [MF],
acetylpyruvate hydrolase activity [MF]
radial pattern formation [BP]
phytoceramidase activity [MF],
phytosphingosine biosynthetic process [BP],
propylene metabolic process [BP]
micro-ribonucleoprotein complex [CC]
negative regulation of high-density lipoprotein particle clearance [BP]
lens fiber cell development [BP]
mitochondrial translational elongation [BP]
carnosine biosynthetic process [BP]
ribosome assembly [BP]
positive regulation of peptidyl-tyrosine autophosphorylation [BP],
negative regulation of bone trabecula formation [BP],
basophil chemotaxis [BP],
receptor agonist activity [MF],
morphogen activity [MF],
negative regulation of bone mineralization involved in bone maturation [BP],
vascular endothelial growth factor receptor binding [MF],
positive regulation of receptor internalization [BP],
vascular endothelial growth factor receptor 2 binding [MF],
positive regulation of branching involved in ureteric bud morphogenesis [BP],
BMP binding [MF],
cell migration involved in sprouting angiogenesis [BP],
gamma-aminobutyric acid import [BP],
negative regulation of monocyte chemotaxis [BP],
regulation of focal adhesion assembly [BP],
positive regulation of protein autophosphorylation [BP],
determination of dorsal identity [BP],
EP4 subtype prostaglandin E2 receptor binding [MF]
clathrin-coated endocytic vesicle membrane [CC],
negative regulation of epidermal growth factor receptor signaling pathway [BP],
clathrin coat [CC]
molecular hydrogen transport [BP],
hydroxyacid-oxoacid transhydrogenase activity [MF]
negative regulation of secretion of lysosomal enzymes [BP]
negative regulation of toll-like receptor 2 signaling pathway [BP],
striated muscle myosin thick filament [CC],
positive regulation of oligodendrocyte progenitor proliferation [BP],
histamine secretion by mast cell [BP],
alpha2-beta1 integrin complex [CC],
positive regulation of dendritic cell apoptotic process [BP],
negative regulation of toll-like receptor 4 signaling pathway [BP],
negative regulation of mast cell proliferation [BP],
Fc receptor mediated inhibitory signaling pathway [BP],
positive regulation of mast cell proliferation [BP],
positive regulation of neurogenesis [BP],
protein ubiquitination involved in ubiquitin-dependent protein catabolic process [BP],
positive regulation of Fc receptor mediated stimulatory signaling pathway [BP]
calcium-dependent cell-cell adhesion [BP],
cellular response to oleic acid [BP],
calcium ion binding [MF]
positive regulation of dense core granule biogenesis [BP]
photoreceptor cell outer segment organization [BP],
prolactin receptor binding [MF]
type I interferon binding [MF]
termination of RNA polymerase III transcription [BP]
mitochondrial threonyl-tRNA aminoacylation [BP],
negative regulation of protein glycosylation in Golgi [BP]
dichotomous subdivision of terminal units involved in mammary gland duct morphogenesis [BP],
chromatin maintenance [BP],
mitochondrial ncRNA surveillance [BP],
mitochondrial RNA 3'-end processing [BP],
neutrophil extravasation [BP],
mitochondrial degradosome [CC],
3'-5' RNA helicase activity [MF],
mitochondrial mRNA catabolic process [BP],
positive regulation of mitochondrial RNA catabolic process [BP],
mitochondrial mRNA surveillance [BP]
optic placode formation involved in camera-type eye formation [BP],
retinal blood vessel morphogenesis [BP],
gastrulation with mouth forming second [BP]
muramyl dipeptide binding [MF],
UDP-N-acetylglucosamine diphosphorylase activity [MF],
positive regulation of dendritic cell cytokine production [BP],
detection of muramyl dipeptide [BP],
response to food [BP],
cellular response to L-ascorbic acid [BP],
negative regulation of glutamine transport [BP],
positive regulation of prostaglandin-E synthase activity [BP]
positive regulation of hepatocyte differentiation [BP],
mitochondrial electron transport, succinate to ubiquinone [BP]
relaxation of skeletal muscle [BP],
positive regulation of fast-twitch skeletal muscle fiber contraction [BP]
procollagen-lysine 5-dioxygenase activity [MF],
synaptic target recognition [BP]
histamine uptake [BP],
intrahepatic bile duct development [BP],
regulation of cell proliferation involved in tissue homeostasis [BP],
notochord development [BP],
epithelial cell proliferation involved in prostatic bud elongation [BP],
heart valve development [BP],
leading strand elongation [BP],
heart valve formation [BP]
monocarboxylic acid transmembrane transporter activity [MF],
zygotene [BP]
JUN kinase phosphatase activity [MF],
acetyl-CoA:L-glutamate N-acetyltransferase activity [MF],
negative regulation of protein glycosylation in Golgi [BP]
negative regulation of vascular endothelial growth factor signaling pathway [BP],
negative regulation of endothelial cell chemotaxis [BP],
positive regulation of blood vessel remodeling [BP],
U4/U6 x U5 tri-snRNP complex [CC],
U4/U6 snRNP [CC]
positive regulation of granzyme B production [BP],
positive regulation of immunoglobulin production in mucosal tissue [BP],
positive regulation of T-helper 1 cell cytokine production [BP],
diolein transacylation activity [MF],
positive regulation of CD8-positive, alpha-beta T cell proliferation [BP],
mono-olein transacylation activity [MF],
positive regulation of granzyme A production [BP],
positive regulation of CD4-positive, alpha-beta T cell proliferation [BP],
negative regulation of T-helper 1 cell activation [BP],
mature natural killer cell chemotaxis [BP]
sarcoplasmic reticulum membrane [CC]
HLH domain binding [MF],
fibrillar center [CC]
group III metabotropic glutamate receptor activity [MF],
serine binding [MF],
adenylate cyclase inhibitor activity [MF],
interleukin-12 beta subunit binding [MF],
interleukin-12 complex [CC],
sensory perception of sound [BP],
interleukin-27 binding [MF]
Wnt receptor catabolic process [BP],
negative regulation of corticotropin-releasing hormone receptor activity [BP],
cellular response to cocaine [BP],
negative regulation of corticotropin secretion [BP],
cellular response to gonadotropin-releasing hormone [BP]
protein K11-linked ubiquitination [BP],
protein K48-linked ubiquitination [BP]
NURF complex [CC],
hyaluranon cable [CC],
CAF-1 complex [CC],
D-xylose catabolic process [BP],
D-xylose 1-dehydrogenase (NADP+) activity [MF],
positive regulation of hyaluranon cable assembly [BP]
exogenous lipid antigen binding [MF],
regulation of myosin II filament organization [BP]
apoptotic process involved in heart morphogenesis [BP]
positive regulation of skeletal muscle contraction by regulation of release of sequestered calcium ion [BP]
sympathetic nervous system development [BP],
thymus development [BP],
sex differentiation [BP]
interleukin-21 receptor activity [MF]
RNA-3'-phosphate cyclase activity [MF]
stilbene catabolic process [BP],
4-nitrophenylphosphatase activity [MF],
lipid phosphatase activity [MF]
ventral midline determination [BP],
positive regulation of oligodendrocyte progenitor proliferation [BP],
detection of cell density by contact stimulus involved in contact inhibition [BP],
alpha2-beta1 integrin complex [CC],
positive regulation of dendritic cell apoptotic process [BP],
negative regulation of mast cell proliferation [BP],
mesenchymal to epithelial transition involved in metanephric renal vesicle formation [BP],
positive regulation of neuron projection development [BP]
mitochondrial matrix [CC],
lipoprotein transporter activity [MF],
negative regulation of platelet-derived growth factor receptor-beta signaling pathway [BP]
cholest-5-ene-3-beta,7-alpha-diol 3-beta-dehydrogenase activity [MF],
pseudouridylate synthase activity [MF],
N-acetylglucosamine-6-phosphate deacetylase activity [MF]
mevalonate kinase activity [MF],
phospholipid-hydroperoxide glutathione peroxidase activity [MF],
dolichyldiphosphatase activity [MF],
negative regulation of cell differentiation involved in embryonic placenta development [BP]
structural constituent of bone [MF],
Edg-2 lysophosphatidic acid receptor binding [MF],
beta-adrenergic receptor kinase activity [MF],
response to vitamin K [BP],
response to hydroxyisoflavone [BP]
acetylgalactosaminyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase activity [MF]
ICAM-3 receptor activity [MF]
malonyl-CoA decarboxylase activity [MF]
positive regulation of oligodendrocyte progenitor proliferation [BP],
positive regulation of dendritic cell apoptotic process [BP],
alpha2-beta1 integrin complex [CC],
negative regulation of mast cell proliferation [BP],
leucyl-tRNA aminoacylation [BP]
DNA binding, bending [MF]
collagen type V [CC],
cellular response to mechanical stimulus [BP],
positive regulation of hyaluronan biosynthetic process [BP],
negative regulation of interleukin-12 biosynthetic process [BP],
regulation of histone H3-K9 acetylation [BP],
regulation of transcription from RNA polymerase II promoter in response to UV-induced DNA damage [BP],
histone H3-T11 phosphorylation [BP],
negative regulation of calcidiol 1-monooxygenase activity [BP],
histone kinase activity (H3-T11 specific) [MF]
positive regulation of calcium-independent cell-cell adhesion [BP],
chromaffin granule lumen [CC],
syntaxin binding [MF]
negative regulation of vascular wound healing [BP],
B cell differentiation [BP],
positive regulation of interleukin-13 biosynthetic process [BP],
purine-nucleoside phosphorylase activity [MF],
inosine catabolic process [BP],
positive regulation of leukotriene production involved in inflammatory response [BP],
protease binding [MF],
B-1 B cell differentiation [BP],
nicotinamide riboside catabolic process [BP],
oxidoreductase activity, oxidizing metal ions with flavin as acceptor [MF],
T cell activation [BP]
detection of chemical stimulus involved in sensory perception of sweet taste [BP],
GMP reductase activity [MF],
sweet taste receptor activity [MF]
positive regulation of abscisic acid mediated signaling pathway [BP]
type 5 melanocortin receptor binding [MF],
positive regulation of female receptivity [BP],
neurohypophyseal hormone activity [MF],
endosomal lumen acidification [BP],
type 1 melanocortin receptor binding [MF],
oxytocin receptor binding [MF],
positive regulation of norepinephrine secretion [BP],
corticotropin hormone receptor binding [MF],
male mating behavior [BP]
RNA polymerase I CORE element sequence-specific DNA binding [MF],
RNA polymerase I core factor complex [CC],
RNA polymerase I transcriptional preinitiation complex assembly at the promoter for the nuclear large rRNA transcript [BP]
GMP catabolic process [BP],
hypoxanthine salvage [BP],
positive regulation of dopamine metabolic process [BP],
GMP salvage [BP],
guanine salvage [BP],
adenine salvage [BP],
IMP salvage [BP],
toxin biosynthetic process [BP],
hypoxanthine metabolic process [BP],
hypoxanthine phosphoribosyltransferase activity [MF],
guanine phosphoribosyltransferase activity [MF],
purine ribonucleoside salvage [BP]
positive regulation of dendritic cell apoptotic process [BP],
endonuclease activity [MF],
alpha2-beta1 integrin complex [CC],
negative regulation of mast cell proliferation [BP],
N-acetylglucosamine kinase activity [MF]
arsenite transmembrane transporter activity [MF],
quinolinate catabolic process [BP]
glucose-6-phosphate isomerase activity [MF],
toll-like receptor 1 signaling pathway [BP],
triacyl lipopeptide binding [MF],
methylglyoxal biosynthetic process [BP],
induction by symbiont of defense-related host nitric oxide production [BP],
chloramphenicol transport [BP],
lipopolysaccharide-mediated signaling pathway [BP]
deoxyribonuclease II activity [MF],
condensin core heterodimer [CC],
hypoxia-inducible factor-1alpha signaling pathway [BP]
positive regulation of GTP catabolic process [BP],
L-pipecolate oxidase activity [MF],
sarcosine oxidase activity [MF]
methionine adenosyltransferase regulator activity [MF],
positive regulation of mismatch repair [BP],
anterior compartment pattern formation [BP],
methionine adenosyltransferase complex [CC],
extracellular polysaccharide biosynthetic process [BP],
dTDP-4-dehydrorhamnose reductase activity [MF],
posterior compartment specification [BP]
regulation of mitotic anaphase [BP],
diacylglycerol cholinephosphotransferase activity [MF]
negative regulation of forebrain neuron differentiation [BP],
negative regulation of stomach neuroendocrine cell differentiation [BP],
negative regulation of pancreatic A cell differentiation [BP],
positive regulation of chemokine (C-C motif) ligand 5 production [BP],
condensin core heterodimer [CC],
positive regulation of IP-10 production [BP],
lateral inhibition [BP],
negative regulation of auditory receptor cell differentiation [BP],
regulation of transcription involved in S phase of mitotic cell cycle [BP],
renal interstitial cell development [BP],
positive regulation of mitotic cell cycle, embryonic [BP]
phosphopantothenate--cysteine ligase activity [MF]
positive regulation of bone mineralization [BP],
phospholipase C-activating angiotensin-mediated signaling pathway [BP],
dentinogenesis [BP],
osteoclast maturation [BP]
oxoglutarate dehydrogenase complex [CC],
positive regulation of corticosterone secretion [BP],
olfactory bulb mitral cell layer development [BP],
substance P receptor binding [MF]
cytoskeletal adaptor activity [MF],
indoleamine 2,3-dioxygenase activity [MF]
kinocilium [CC]
cleavage body [CC],
DNA/RNA helicase activity [MF]
virion attachment, binding of host cell surface coreceptor [BP],
triglyceride binding [MF],
sperm mitochondrion organization [BP]
gastric inhibitory peptide receptor activity [MF],
cellular creatinine homeostasis [BP],
cellular ammonia homeostasis [BP]
mitochondrion [CC]
negative regulation of phosphatidylcholine catabolic process [BP]
islet amyloid polypeptide processing [BP],
interleukin-21-mediated signaling pathway [BP],
(R)-2-hydroxyglutarate dehydrogenase activity [MF],
interleukin-21 receptor activity [MF]
protein C inhibitor-thrombin complex [CC],
calmodulin-lysine N-methyltransferase activity [MF],
protein C inhibitor-coagulation factor V complex [CC],
protein C inhibitor-TMPRSS7 complex [CC],
protein C inhibitor-coagulation factor Xa complex [CC],
protein C inhibitor-KLK3 complex [CC],
protein C inhibitor-TMPRSS11E complex [CC],
protein C inhibitor-coagulation factor XI complex [CC],
protein C inhibitor-PLAU complex [CC],
protein C inhibitor-plasma kallikrein complex [CC]
male pronucleus assembly [BP]
toxin biosynthetic process [BP],
leptotene [BP]
phosphorylation of RNA polymerase II C-terminal domain [BP]